தலை ஆஃப் தி துறை பெண்ணோயியல் மகப்பேறியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தலை ஆஃப் தி துறை பெண்ணோயியல் மகப்பேறியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தலை ஆஃப் தி துறை பெண்ணோயியல் மகப்பேறியல் Today - Breaking & Trending Today

DETECT program studies validate clinical relevance of CTC HER2 phenotypes in metastatic breast cancer patients with HER2 negative primary tumor and positive impact of reference anti-HER2 treatment on overall survival

(1)
Results presented at the 2020 San Antonio Breast Cancer Symposium confirm the relevance of screening for HER2+ CTCs from blood samples in patients with a HER2 negative primary tumor biopsy to optimize treatment strategy and patient outcome
BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 10, 2020 /PRNewswire/ Menarini Silicon Biosystems, a pioneer of liquid biopsy technology, announced today new data from the DETECT study program. These data focused on women with HER2 negative metastatic breast cancer (MBC) based on primary tumor biopsy, and HER2
+ CTCs. The results of this large program demonstrate that screening for HER2+ CTCs, in the blood samples of these patients, is an important tool to guide therapy decisions and improve patient outcomes. Furthermore, the randomized DETECT III phase III study, discussed in a poster spotlight session during the 2020 San Antonio Breast Cancer Symposium, shows that adding reference HER2 targeted TKI (tyrosine kinase inhibitor) ....

San Antonio , United States , Cecilia Simonelli , Kostenloser Wertpapierhandel , Tanjan Fehm , Linda Pavy , Heinrich Heine University , Head Of The Department Gynecology Obstetrics , Us Food Drug Administration , China National Medical Products Administration , Research Use , Menarini Group , Antonio Breast Cancer Symposium , Silicon Biosystems , Menarini Silicon Biosystem , Global Medical Affairs Head , Menarini Silicon , Circulating Tumor Cell , Drug Administration , Metastatic Breast , Tumor Cell Kit , Phenotyping Reagent , Huntingdon Valley , சான் அன்டோனியோ , ஒன்றுபட்டது மாநிலங்களில் , சிசிலியா சீமோநெல்லி ,

DETECT program studies validate clinical relevance of CTC HER2 phenotypes in metastatic breast cancer patients with HER2 negative primary tumor a | ANP Pers Support

DETECT program studies validate clinical relevance of CTC HER2 phenotypes in metastatic breast cancer patients with HER2 negative primary tumor a | ANP Pers Support
perssupport.nl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from perssupport.nl Daily Mail and Mail on Sunday newspapers.

San Antonio , United States , Cecilia Simonelli , Tanjan Fehm , Linda Pavy , Heinrich Heine University , Head Of The Department Gynecology Obstetrics , Us Food Drug Administration , China National Medical Products Administration , Research Use , Menarini Group , Antonio Breast Cancer Symposium , Silicon Biosystems , Menarini Silicon Biosystem , Global Medical Affairs Head , Menarini Silicon , Circulating Tumor Cell , Drug Administration , Metastatic Breast , Tumor Cell Kit , Tumor Phenotyping Reagent , Huntingdon Valley , சான் அன்டோனியோ , ஒன்றுபட்டது மாநிலங்களில் , சிசிலியா சீமோநெல்லி , ஹென்ரிச் ஹெய்ன் பல்கலைக்கழகம் ,